Xiaojing Liu
YOU?
Author Swipe
View article: Unravelling tandem repeat-mediated mutagenesis drive rapid diversification of KPC enzymes: emergence of blaKPC-263 and enhanced resistance to ceftazidime-avibactam
Unravelling tandem repeat-mediated mutagenesis drive rapid diversification of KPC enzymes: emergence of blaKPC-263 and enhanced resistance to ceftazidime-avibactam Open
This work was funded by the National Key R&D Programme of China (2023YFC2308400); National Natural Science Foundation of China (82072314); Shandong Provincial Laboratory Project (SYS202202); Zhejiang Province Leading Geese Plan (2025C04013…
View article: Genomic insights and epidemiology of mcr-1-Carrying Escherichia albertii isolated from agricultural soil in China
Genomic insights and epidemiology of mcr-1-Carrying Escherichia albertii isolated from agricultural soil in China Open
Our findings offer new insights into the epidemiology and genomic features of mcr-1-carrying E. albertii, underscoring the need for targeted management strategies to curb its spread. These findings underscore the importance of "One Health"…
View article: Bifidobacterium Bifidum S17 Attenuates Non-Alcoholic Fatty Liver Disease Induced by High-Alcohol-Producing Klebsiella Pneumoniae
Bifidobacterium Bifidum S17 Attenuates Non-Alcoholic Fatty Liver Disease Induced by High-Alcohol-Producing Klebsiella Pneumoniae Open
View article: Genomic and phenotypic characterization of ST2012 clinical Klebsiella quasipneumoniae subsp. similipneumoniae harboring blaNDM−1 in China
Genomic and phenotypic characterization of ST2012 clinical Klebsiella quasipneumoniae subsp. similipneumoniae harboring blaNDM−1 in China Open
View article: Emergence of plasmid-borne <i>tet</i> (X4) resistance gene in clinical isolate of eravacycline- and omadacycline-resistant <i>Klebsiella pneumoniae</i> ST485
Emergence of plasmid-borne <i>tet</i> (X4) resistance gene in clinical isolate of eravacycline- and omadacycline-resistant <i>Klebsiella pneumoniae</i> ST485 Open
Omadacycline and eravacycline are gradually being used as new tetracycline antibiotics for the clinical treatment of Gram-negative pathogens. Affected by various tetracycline-inactivating enzymes, there have been reports of resistance to e…